Ahren is an investment institution that supports transformational companies at the intersection of deep tech and deep science that will penetrate, or create, massive markets. We believe in taking asymmetric, considered, risk that will deliver superior rewards - capturing a generational opportunity to provide smart capital to deep technology. We partner with stellar founders and teams at all stages from pre-seed to pre-IPO. We gladly help build companies from scratch or are equally happy to provide capital and expertise to high growth businesses.
Ahren has four broad domains of interest including the Brain & AI, Genetics & Platform Technologies, Space & Robotics & Efficient Energy. With a philosophy espousing the importance of relationships and trust, we provide both patient and active capital to exceptional founders and teams, empowering them to achieve the unimaginable.
view all companies
We are a unique partnership of investment talent and best-in-class commercial scientists whose technologies are today valued in excess of $100BN combined.
17 April, 2024
Mentee Robotics Unveils MenteeBot: a humanoid robot that integrates AI across all operational layers
3 August, 2023
Adrestia Acquired by Insmed Incorporated, Bringing its Novel Approach to Tackling Intractable Genetic Diseases to Insmed’s Early-Stage Research Portfolio
18 March, 2022
Direct Air Capture Startup Heirloom Raises $53MM Series A, Among the Largest Investments in New Carbon Removal Technologies
18 December, 2020
GSK and Ahren Announce Co-Led Series A Investment in Adrestia, and Multi-Project Discovery Collaboration with Each of the Five Projects Eligible To Receive Up To $230M (£172M) in Post Option Milestones
